Baillie Gifford - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$4,000
+100.0%
853
+88.7%
0.00%
Q4 2021$2,0000.0%4520.0%0.00%
Q3 2021$2,0000.0%4520.0%0.00%
Q2 2021$2,000
-33.3%
4520.0%0.00%
Q1 2021$3,000
+50.0%
452
-12.6%
0.00%
Q4 2020$2,0005170.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$103,087,0005.89%
Eversept Partners, LP 6,440,572$30,850,3401.97%
TPG GP A, LLC 16,213,367$77,662,0000.78%
Signature Wealth Management Partners, LLC 87,666$420,0000.36%
Hedges Asset Management LLC 75,000$359,0000.28%
Hillsdale Investment Management Inc. 869,916$4,167,0000.28%
Tranquilli Financial Advisor LLC 71,414$342,0000.24%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$862,0000.19%
GLOBEFLEX CAPITAL L P 297,414$1,424,0000.15%
XTX Topco Ltd 23,742$114,0000.06%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders